Amylyx Pharmaceuticals, Inc. (AMLX) Misses Q4 Earnings Estimates

Amylyx Pharmaceuticals, Inc. (AMLX) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of$ 0.20 per share. This compares to loss of $0.65 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -65%. A quarter ago, it was expected that this company would post earnings of$ 0.42 per share when it actually produced earnings of $0.30, delivering a surprise of -28.57%.Over the last four quarters, the ...